Subscribe
Facebook Twitter Instagram Youtube

Nominate your candidate to stand for election as a WHA Regional Board Member.

Nominations are open for candidates to stand for election as the World Hepatitis Alliance (WHA) Regional Board Members for the African (AFRO), Eastern Mediterranean (EMRO) and Western Pacific (WPRO) regions. A new Board member for each of these regions will be elected in December 2019 to begin their two-year term from January 2020.

With the deadline for nominations fast approaching, WHA would like to encourage members to nominate candidates to stand for election. All members can nominate a candidate.

Nominations will close at midnight on Sunday 17 November.

How to nominate a candidate:

  • Carefully review the role description with a particular focus on the person specification to ensure the person you have in mind fulfils all of the criteria for the role. Please note – you can only nominate a candidate for Regional Board Member who resides in the same country as your organisation.
  • Return the nomination form duly completed in English to admin@worldhepatitisalliance.org by 18th November 2018 including ‘WHA 2019 Election’ in the subject line. Please note that the front page of the form must be completed by yourself and page 2-4 by the candidate; failure to follow the instructions stipulated may result in the nomination not being considered.

Click here to download the election process.

Click here to download the Regional Board member role description and person specification. 

Click here to download the Regional Board member nomination form.

Latest News

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close